Identification of an unusual pattern of global gene expression in group B Streptococcus grown in human blood

PLoS ONE

Volumn 4, Issue 9, 2009, Pages

  Mereghetti, Laurent ^a,b,c   Sitkiewicz, Izabela ^a   Green, Nicole M ^a   Musser, James M ^a  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b UNIVERSITÉ DE TOURS   (France)

^c UNIVERSITY HOSPITAL OF TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 7; TISSUE PLASMINOGEN ACTIVATOR; TRANSCRIPTOME; TUMOR NECROSIS FACTOR ALPHA; COMPLEMENTARY DNA; CYTOKINE; RNA;

ARTICLE; BACTERIAL STRAIN; BLOOD CULTURE; BLOOD SAMPLING; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; IMMUNE RESPONSE; NONHUMAN; PATHOGENESIS; PRINCIPAL COMPONENT ANALYSIS; STREPTOCOCCUS AGALACTIAE; UPREGULATION; BACTERIAL GENE; BIOLOGY; BLOOD; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; GENOME; INFLAMMATION; KINETICS; METABOLISM; METHODOLOGY; MICROBIOLOGY; VIRULENCE;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS SP. 'GROUP B';

BLOOD; COMPUTATIONAL BIOLOGY; CYTOKINES; DNA, COMPLEMENTARY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; GENES, BACTERIAL; GENOME; HUMANS; INFLAMMATION; KINETICS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; RNA; STREPTOCOCCUS AGALACTIAE; UP-REGULATION; VIRULENCE;

EID: 70349631221     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007145     Document Type: Article

References (33)

1. van der Mee-Marquet N, Fourny L, Arnault L, Domelier AS, Salloum M, et al. (2008) Molecular characterization of human-colonizing Streptococcus agalactiae strains isolated from throat, skin, anal margin, and genital body sites. J Clin Microbiol 46: 2906-2911.
2. Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, et al. (2008) Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. Jama 299: 2056-2065.
3. Bohnsack JF, Takahashi S, Detrick SR, Pelinka LR, Hammitt LL, et al. (2001) Phylogenetic classification of serotype III group B streptococci on the basis of hylB gene analysis and DNA sequences specific to restriction digest pattern type III-3. J Infect Dis 183: 1694-1697.
4. Hery-Arnaud G, Bruant G, Lanotte P, Brun S, Rosenau A, et al. (2005) Acquisition of insertion sequences and the GBSi1 intron by Streptococcus agalactiae isolates correlates with the evolution of the species. J Bacteriol 187: 6248-6252.
5. Jones N, Bohnsack JF, Takahashi S, Oliver KA, Chan MS, et al. (2003) Multilocus sequence typing system for group B streptococcus. J Clin Microbiol 41: 2530-2536.
6. Musser JM, Mattingly SJ, Quentin R, Goudeau A, Selander RK (1989) Identification of a high-virulence clone of type III Streptococcus agalactiae (group B streptococcus) causing invasive neonatal disease. Proc Natl Acad Sci U S A 86: 4731-4735.
7. Rolland K, Mereghetti L, Watt S, Chatellier S, Quentin R (2002) tRNA gene clusters at the 39 end of rRNA operons are specific to virulent subgroups of Streptococcus agalactiae strains, as demonstrated by molecular differential analysis at the population level. Microbiology 148: 1493-1499.
8. Bisharat N, Crook DW, Leigh J, Harding RM, Ward PN, et al. (2004) Hyperinvasive neonatal group B streptococcus has arisen from a bovine ancestor. J Clin Microbiol 42: 2161-2167.
9. Hery-Arnaud G, Bruant G, Lanotte P, Brun S, Picard B, et al. (2007) Mobile genetic elements provide evidence for a bovine origin of clonal complex 17 of Streptococcus agalactiae. Appl Environ Microbiol 73: 4668-4672.
10. Edwards MS, Baker CJ (2005) Group B streptococcal infections in elderly adults. Clin Infect Dis 41: 839-847.
11. Peleg AY, Weerarathna T, McCarthy JS, Davis TM (2007) Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev 23: 3-13.
12. Glaser P, Rusniok C, Buchrieser C, Chevalier F, Frangeul L, et al. (2002) Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease. Mol Microbiol 45: 1499-1513.
13. Mereghetti L, Sitkiewicz I, Green NM, Musser JM (2008) Extensive adaptive changes occur in the transcriptome of Streptococcus agalactiae (group B streptococcus) in response to incubation with human blood. PLoS ONE 3: e3143.
14. Herbert MA, Beveridge CJ, McCormick D, Aten E, Jones N, et al. (2005) Genetic islands of Streptococcus agalactiae strains NEM316 and 2603VR and their presence in other group B streptococcal strains. BMC Microbiol 5: 31.
15. Mereghetti L, Sitkiewicz I, Green NM, Musser JM (2008) Remodeling of the Streptococcus agalactiae transcriptome in response to growth temperature. PLoS ONE 3: e2785.
16. Musser JM, DeLeo FR (2005) Toward a genome-wide systems biology analysis of host-pathogen interactions in group A streptococcus. Am J Pathol 167: 1461-1472.
17. Virtaneva K, Porcella SF, Graham MR, Ireland RM, Johnson CA, et al. (2005) Longitudinal analysis of the group A streptococcus transcriptome in experimental pharyngitis in cynomolgus macaques. Proc Natl Acad Sci U S A 102: 9014-9019.
18. Loughman JA, Caparon MG (2006) A novel adaptation of aldolase regulates virulence in Streptococcus pyogenes. Embo J 25: 5414-5422.
19. Shelburne SA 3rd, Keith D, Horstmann N, Sumby P, Davenport MT, et al. (2008) A direct link between carbohydrate utilization and virulence in the major human pathogen group A streptococcus. Proc Natl Acad Sci U S A 105: 1698-1703.
20. Kotb M, Norrby-Teglund A, McGeer A, Green K, Low DE (2003) Association of human leukocyte antigen with outcomes of infectious diseases: the streptococcal experience. Scand J Infect Dis 35: 665-669.
21. Liang FT, Yan J, Mbow ML, Sviat SL, Gilmore RD, et al. (2004) Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses. Infect Immun 72: 5759-5767.
22. Sendi P, Johansson L, Dahesh S, Van-Sorge NM, Darenberg J, et al. (2009) Bacterial phenotype variants in group B streptococcal toxic shock syndrome. Emerg Infect Dis 15: 223-232.
23. Sigge A, Schmid M, Mauerer S, Spellerberg B (2008) Heterogeneity of hemolysin expression during neonatal Streptococcus agalactiae sepsis. J Clin Microbiol 46: 807-809.
24. Katial RK, Sachanandani D, Pinney C, Lieberman MM (1998) Cytokine production in cell culture by peripheral blood mononuclear cells from immunocompetent hosts. Clin Diagn Lab Immunol 5: 78-81.
25. Wang SM, Lu IH, Lin YL, Lin YS, Wu JJ, et al. (2008) The severity of Streptococcus pyogenes infections in children is significantly associated with plasma levels of inflammatory cytokines. Diagn Microbiol Infect Dis 61: 165-169.
26. Alessi MC, Poggi M, Juhan-Vague I (2007) Plasminogen activator inhibitor-1, adipose tissue and insulin resistance. Curr Opin Lipidol 18: 240-245.
27. Leurs PB, Stolk RP, Hamulyak K, Van Oerle R, Grobbee DE, et al. (2002) Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes. Diabetes Care 25: 1340-1345.
28. Festa A, D'Agostino R Jr, Tracy RP, Haffner SM (2002) Elevated levels of acutephase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 51: 1131-1137.
29. Toso C, Emamaullee JA, Merani S, Shapiro AM (2008) The role of macrophage migration inhibitory factor on glucose metabolism and diabetes. Diabetologia 51: 1937-1946.
30. Yabunaka N, Nishihira J, Mizue Y, Tsuji M, Kumagai M, et al. (2000) Elevated serum content of macrophage migration inhibitory factor in patients with type 2 diabetes. Diabetes Care 23: 256-258.
31. Calandra T, Bernhagen J, Mitchell RA, Bucala R (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 179: 1895-1902.
32. Calandra T (2003) Macrophage migration inhibitory factor and host innate immune responses to microbes. Scand J Infect Dis 35: 573-576.
33. Kornelisse RF, Hazelzet JA, Savelkoul HF, Hop WC, Suur MH, et al. (1996) The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock. J Infect Dis 173: 1148-1156.